enprofylline has been researched along with Status Asthmaticus in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Status Asthmaticus: A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five different doses of enprofylline, a 3-propylxanthine, were compared with a standard dose of theophylline in 135 episodes of acute asthma in a double-blind study." | 9.06 | Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma. ( Boe, J; Eriksson, G; Ljungholm, K, 1987) |
| "Five different doses of enprofylline, a 3-propylxanthine, were compared with a standard dose of theophylline in 135 episodes of acute asthma in a double-blind study." | 5.06 | Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma. ( Boe, J; Eriksson, G; Ljungholm, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boe, J | 1 |
| Eriksson, G | 1 |
| Ljungholm, K | 1 |
1 trial available for enprofylline and Status Asthmaticus
| Article | Year |
|---|---|
Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma.
Topics: Adult; Aged; Asthma; Blood Pressure; Bronchodilator Agents; Female; Heart Rate; Humans; Male; Middle | 1987 |